Morgan Stanley analyst Matthew Harrison upgraded shares of Regeneron (NASDAQ: REGN) to Overweight from Equal-Weight, raising the firm's price target ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE